A randomized, placebo-controlled study of oral cimetidine as an immunopotentiator of parenteral immunization with a group B meningococcal vaccine.

Drabick, J J; Tang, D B; Moran, E E; Trofa, A F; Foster, J S; Zollinger, W D

Drabick, J J; Tang, D B; Moran, E E; Trofa, A F; Foster, J S; Zollinger, W D.

Affiliation

Drabick JJ; Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.

Vaccine ; 15(10): 1144-8, 1997 Jul.

Article in En | MEDLINE | ID: mdl-9269060

Subject(s)

Adjuvants, Immunologic/administration & dosage; Bacterial Vaccines/administration & dosage; Cimetidine/administration & dosage; Histamine H2 Antagonists/administration & dosage; Neisseria meningitidis/immunology; Administration, Oral; Adolescent; Adult; Antibodies, Bacterial/blood; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Meningitis, Meningococcal/immunology; Meningitis, Meningococcal/prevention & control; Meningococcal Vaccines; Neisseria meningitidis/classification

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Vaccines / Adjuvants, Immunologic / Cimetidine / Histamine H2 Antagonists / Neisseria meningitidis Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Vaccine Year: 1997 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links